Skip to content

COLL

Collegium Pharmaceutical, Inc.

NASDAQ · USHealthcareDrug Manufacturers - Specialty & Generic
$35.54-1.50%

Price as of Jul 20, 2026

COLL analysis

Collegium Pharmaceutical, Inc. stock analysis

Published Drillr research and company-specific analysis. Existing articles keep their current URLs and citation behavior.

Analysis for COLL is not published yet

Browse the public research library while company-specific analysis is being prepared. Explore research